Are Things Looking Up For Karyopharm Therapeutics Inc (NASDAQ: KPTI)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Karyopharm Therapeutics Inc is $181.81M. A total of 1.47 million shares were traded on the day, compared to an average of 1.76M shares.

In the most recent transaction, Paulson Richard A. sold 3,573 shares of KPTI for 1.30 per share on Mar 05 ’24. After the transaction, the President and CEO now owns 1,160,836 company shares. In a previous transaction on Mar 01 ’24, Paulson Richard A. sold 19,374 shares at 1.20 per share. KPTI shares that President and CEO owns now total 1,164,409.

Among the insiders who sold shares, Mason Michael disposed of 6,162 shares on Mar 01 ’24 at a per-share price of $1.20. This resulted in the EVP, CFO & Treasurer holding 398,756 shares of KPTI after the transaction. In another insider transaction, Poulton Stuart sold 6,155 shares at $1.20 per share on Mar 01 ’24. Company shares held by the EVP, Chief Development Officer now total 329,511.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, KPTI has a high of $4.87 and a low of $0.62.

As of this writing, KPTI has an earnings estimate of -$0.33 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.28 per share and a lower estimate of -$0.37. The company reported an EPS of -$0.3 in the last quarter, which was -7.10% lower than expectations of -$0.28.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. KPTI’s latest balance sheet shows that the firm has $228.62M in Cash & Short Term Investments as of fiscal 2021. There were $180.58M in debt and $73.72M in liabilities at the time. Its Book Value Per Share was -$1.19, while its Total Shareholder’s Equity was -$79.67M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KPTI is Buy with a score of 4.57.

Most Popular

Related Posts